New Double Lung Transplant Technique for Late-Stage Cancer Patients

New Double Lung Transplant Technique for Late-Stage Cancer Patients

Surgeons at North-western Medicine in Chicago recently successfully performed double lung transplantations in two patients suffering from stage 4 cancer.

When cancer spreads from one lung to the other and doesn't respond to standard treatments, patients are left with no options. However, Dr. Ankit Bharat, the chief of thoracic surgery and the director of the North-western Medicine Canning Thoracic Institute, said, "We are going to consider this only when all the options have been exhausted."

Transplanting one lung at a time has historically been the standard procedure for cancer patients. However, it has some risks, such as the remaining cancerous lung can infect the new lung with cancer, and the incisions can infiltrate the cancer cells into the bloodstream. 

Bharat and his team at North-western thus opted for a different approach.

They replaced both cancerous lungs at the same time with two healthy transplanted lungs to significantly lower the risk of cancer cells penetrating the new organs or other regions of the body. 

This approach, however, is not feasible for all stage 4 lung cancer patients but is only for those in whom cancer is limited to the lungs but not beyond that. 

Highlighting the challenges, Dr. William Dahut, the chief scientific officer of the American Cancer Society, said, "Determining the right patient is s huge task. The person undergoing the treatment must be able to tolerate both the surgery as well as the immunosuppressive therapies prescribed after the transplant." 

North-western's program, termed North-western Medicine's Double Lung Replacement and Multidisciplinary Care, or DREAM, intends to identify the first 75 cancer patients to get a double-lung transplant. What they learn from these patients will also help other surgery centres perform the procedure.

IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team


Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks